Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

135. Aicardi syndrome Disease details / Clinical trials / Drug dev / DR info /

Clinical trials : 2 / Drugs : 12 - (DrugBank : 4) / Drug target genes : 2 - Drug target pathways : 37

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

Abacavir
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France
Baricitinib
   Eli Lilly and Company
      -   Phase 2;Phase 3   EUCTR2025-000001-16-Outside-EU/EEA   Japan
Epivir
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France
GX 623
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France
GX CJ7
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France
J05A F01
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France
Lamivudine
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France
LY3009104
   Eli Lilly and Company
      -   Phase 2;Phase 3   EUCTR2025-000001-16-Outside-EU/EEA   Japan
Olumiant
   Eli Lilly and Company
      -   Phase 2;Phase 3   EUCTR2025-000001-16-Outside-EU/EEA   Japan
Retrovir
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France
Ziagen
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France
Zidovudine
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France